Florenzo Iannone Selected Research

Serositis

1/2022	Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
1/2021	The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
9/2020	Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Florenzo Iannone Research Topics

Disease

56	Rheumatoid Arthritis 10/2022 - 08/2005
22	Psoriatic Arthritis 01/2022 - 07/2012
20	Uveitis 07/2020 - 05/2014
17	Arthritis (Polyarthritis) 11/2022 - 03/2011
15	Necrosis 10/2022 - 02/2007
12	Infections 09/2022 - 12/2012
11	Systemic Scleroderma (Systemic Sclerosis) 11/2021 - 03/2005
10	Axial Spondyloarthritis 11/2022 - 07/2018
10	Inflammation (Inflammations) 01/2022 - 07/2012
10	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021 - 01/2015
8	Rheumatic Diseases (Rheumatism) 01/2022 - 05/2014
7	Vasculitis (Vasculitides) 01/2022 - 06/2016
7	Fever (Fevers) 07/2021 - 01/2014
7	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 08/2015
7	Behcet Syndrome (Behcet's Syndrome) 11/2020 - 10/2015
6	Obesity 11/2021 - 05/2015
6	Adult-Onset Still's Disease 01/2021 - 05/2016
6	Ankylosing Spondylitis 01/2020 - 11/2016
5	Latent Tuberculosis 09/2022 - 05/2014
4	Dermatomyositis (Dermatopolymyositis) 10/2022 - 09/2006
4	COVID-19 10/2022 - 01/2021
4	Joint Diseases (Joint Disease) 05/2022 - 11/2016
4	Pericarditis 01/2022 - 01/2015
4	Pulmonary Arterial Hypertension 11/2021 - 01/2017
4	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2020 - 07/2012
4	Exanthema (Rash) 01/2020 - 09/2006
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2019 - 05/2014
3	Polymyositis 10/2022 - 01/2017
3	Neoplasms (Cancer) 09/2022 - 01/2018
3	Hepatitis B 03/2022 - 07/2015
3	Serositis 01/2022 - 09/2020
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 10/2019
3	Lymphadenopathy 10/2020 - 01/2015
3	Anterior Uveitis 06/2020 - 11/2016
3	Antisynthetase syndrome 11/2019 - 08/2015
3	Overweight 08/2019 - 05/2015
3	Fibrosis (Cirrhosis) 01/2019 - 10/2005
3	Macular Edema 01/2019 - 01/2017
3	Retinal Vasculitis 10/2018 - 01/2017
3	autosomal dominant familial Periodic fever 05/2015 - 09/2014
2	Fibromyalgia (Fibrositis) 09/2022 - 01/2020
2	Raynaud Disease (Raynaud's Disease) 01/2022 - 01/2019
2	digital ulcers 01/2022 - 02/2019
2	Pain (Aches) 07/2021 - 02/2007
2	Deglutition Disorders (Dysphagia) 01/2021 - 06/2015

Drug/Important Bio-Agent (IBA)

35	Biological ProductsIBA 09/2022 - 05/2015
23	Pharmaceutical PreparationsIBA 11/2022 - 06/2012
22	Antirheumatic Agents (DMARD)IBA 11/2022 - 12/2012
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2020 - 09/2006
20	Infliximab (Remicade)FDA Link 01/2022 - 08/2005
18	Tumor Necrosis Factor InhibitorsIBA 11/2022 - 11/2016
17	Adalimumab (Humira)FDA Link 02/2022 - 06/2012
14	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 04/2015
13	Etanercept (Enbrel)FDA Link 01/2021 - 09/2006
10	SteroidsIBA 01/2022 - 12/2012
10	CytokinesIBA 11/2021 - 01/2014
10	Interleukin-1 (Interleukin 1)IBA 01/2021 - 09/2014
10	tocilizumab (atlizumab)FDA Link 01/2020 - 05/2016
9	C-Reactive ProteinIBA 05/2022 - 02/2007
9	InterleukinsIBA 01/2022 - 01/2015
9	AntibodiesIBA 01/2021 - 12/2003
8	Abatacept (Orencia)FDA Link 10/2022 - 07/2012
8	Methotrexate (Mexate)FDA LinkGeneric 09/2022 - 02/2014
8	Rituximab (Mabthera)FDA Link 03/2022 - 12/2014
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 05/2014
7	AutoantibodiesIBA 01/2022 - 01/2014
7	canakinumab FDA Link 01/2020 - 04/2015
6	secukinumabIBA 01/2022 - 07/2018
5	Ligases (Synthetase)IBA 10/2022 - 09/2016
5	ametantrone (HAQ)IBA 09/2022 - 02/2007
4	GlucocorticoidsIBA 01/2022 - 11/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2015
4	golimumab FDA Link 01/2021 - 01/2017
4	Monoclonal AntibodiesIBA 07/2020 - 06/2015
4	Certolizumab Pegol FDA Link 07/2019 - 12/2016
4	Fluorescein (Funduscein)FDA LinkGeneric 07/2017 - 01/2017
3	BNT162 VaccineIBA 10/2022 - 01/2022
3	LipidsIBA 01/2022 - 11/2014
3	VaccinesIBA 01/2022 - 07/2021
3	Colchicine FDA LinkGeneric 01/2022 - 01/2020
3	CholesterolIBA 01/2022 - 01/2020
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 09/2019
3	CT-P13IBA 01/2022 - 01/2021
3	Interleukin-10 (Interleukin 10)IBA 11/2021 - 01/2008
3	Biosimilar PharmaceuticalsIBA 09/2021 - 01/2019
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 04/2019
3	InflammasomesIBA 01/2021 - 01/2015
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 06/2015
3	baricitinibIBA 01/2020 - 01/2019
3	CollagenIBA 02/2019 - 10/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2005
2	Antinuclear AntibodiesIBA 01/2022 - 01/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 11/2021
2	COVID-19 VaccinesIBA 01/2022 - 07/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	AdipokinesIBA 11/2021 - 06/2018
2	Nicotinamide PhosphoribosyltransferaseIBA 11/2021 - 06/2018

Therapy/Procedure

31	Therapeutics 11/2022 - 01/2008
14	Biological Therapy 11/2020 - 05/2014